Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.8 |
mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |